Shrikant Anant

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 26

Top Venues

Cell death & disease

Cancers

bioRxiv : the preprint server for biology

Cell death discovery

University of Kansas Cancer Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Kansas Cancer Center Jul 01 2018

United States

Associate Director- Basic Sciences

University of Kansas Medical Center Jul 01 2018

United States

Professor and Chair :: Cancer Biology

University of Kansas Medical Center Jul 01 2016 - Jun 30 2018

United States

Professor and ViceChair for Research :: General Surgery

University of Kansas Cancer Center Jul 01 2010 - Jun 30 2018

United States

Associate Director of Prevention and Cancer Control

University of Kansas Medical Center Jul 01 2010 - Jun 30 2017

United States

Professor :: Molecular and Integrative Physiology

University of Oklahoma Health Sciences Center Jul 01 2006 - Jun 30 2010

United States

Associate Professor, Director of Gastroenterology Research :: Internal Medicine and Cell Biology

Washington University School of Medicine in St. Louis Aug 01 1998 - Jun 30 2006

United States

Assistant Professor :: Internal Medicine and Pharmacology

University of Chicago Jul 01 1995 - Jun 30 1998

United States

Instructor :: Internal Medicine

Publications

David Standing, Prasad Dandawate, Sumedha Gunewardena, Obdulia Covarrubias-Zambrano, Katherine F Roby, Dineo Khabele, Andrea Jewell, Ossama Tawfik, Stefan H Bossmann, Andrew K Godwin, Scott J Weir, Roy A Jensen, Shrikant Anant
Selective targeting of IRAK1 attenuates low molecular weight hyaluronic acid-induced stemness and non-canonical STAT3 activation in epithelial ovarian cancer. Cell death & disease 15 (5) (2024)
Levi Arnold, Marion Yap, Laura Jackson, Michael Barry, Thuc Ly, Austin Morrison, Juan P Gomez, Michael P Washburn, David Standing, Nanda Kumar Yellapu, Linheng Li, Shahid Umar, Shrikant Anant, Sufi Mary Thomas
DCLK1-Mediated Regulation of Invadopodia Dynamics and Matrix Metalloproteinase Trafficking Drives Invasive Progression in Head and Neck Squamous Cell Carcinoma. bioRxiv : the preprint server for biology (2024)
Levi Arnold, Marion Yap, Laura Jackson, Michael Barry, Thuc Ly, Austin Morrison, Juan P Gomez, Michael P Washburn, David Standing, Nanda Kumar Yellapu, Linheng Li, Shahid Umar, Shrikant Anant, Sufi Mary Thomas
DCLK1-Mediated Regulation of Invadopodia Dynamics and Matrix Metalloproteinase Trafficking Drives Invasive Progression in Head and Neck Squamous Cell Carcinoma. bioRxiv : the preprint server for biology (2024)
David Standing, Prasad Dandawate, Sumedha Gunewardena, Obdulia Covarrubias-Zambrano, Katherine F Roby, Dineo Khabele, Andrea Jewell, Ossama Tawfik, Stefan H Bossmann, Andrew K Godwin, Scott J Weir, Roy A Jensen, Shrikant Anant
Selective targeting of IRAK1 attenuates low molecular weight hyaluronic acid-induced stemness and non-canonical STAT3 activation in epithelial ovarian cancer. Cell death & disease 15 (5) (2024)
David Standing, Prasad Dandawate, Sumedha Gunewardena, Obdulia Covarrubias-Zambrano, Katherine F Roby, Dineo Khabele, Andrea Jewell, Ossama Tawfik, Stefan H Bossmann, Andrew K Godwin, Scott J Weir, Roy A Jensen, Shrikant Anant
Selective targeting of IRAK1 attenuates low molecular weight hyaluronic acid-induced stemness and non-canonical STAT3 activation in epithelial ovarian cancer. Cell death & disease 15 (5) (2024)
Levi Arnold, Marion Yap, Laura Jackson, Michael Barry, Thuc Ly, Austin Morrison, Juan P Gomez, Michael P Washburn, David Standing, Nanda Kumar Yellapu, Linheng Li, Shahid Umar, Shrikant Anant, Sufi Mary Thomas
DCLK1-Mediated Regulation of Invadopodia Dynamics and Matrix Metalloproteinase Trafficking Drives Invasive Progression in Head and Neck Squamous Cell Carcinoma. bioRxiv : the preprint server for biology (2024)
David Standing, Prasad Dandawate, Sumedha Gunewardena, Obdulia Covarrubias-Zambrano, Katherine F Roby, Dineo Khabele, Andrea Jewell, Ossama Tawfik, Stefan H Bossmann, Andrew K Godwin, Scott J Weir, Roy A Jensen, Shrikant Anant
Selective targeting of IRAK1 attenuates low molecular weight hyaluronic acid-induced stemness and non-canonical STAT3 activation in epithelial ovarian cancer. Cell death & disease 15 (5) (2024)
Levi Arnold, Juan Pineda Gomez, Michael Barry, Marrion Yap, Laura Jackson, Thuc Ly, David Standing, Subhash B Padhye, Bernhard Biersack, Shrikant Anant, Sufi Mary Thomas
Acryl-3,5-bis(2,4-difluorobenzylidene)-4-piperidone targeting cellular JUN proto-oncogene, AP-1 transcription factor subunit inhibits head and neck squamous cell carcinoma progression. Exploration of targeted anti-tumor therapy 4 (5) (2023)
Sangita Bhattacharyya, Hindole Ghosh, Obdulia Covarrubias-Zambrano, Krishan Gopal Jain, K Venkateswara Swamy, Anup Kasi, Ameer Hamza Md, Shrikant Anant, Michael VanSaun, Scott J Weir, Stefan H Bossmann, Subhash B Padhye, Prasad Dandawate
Anticancer Activity of Novel Difluorinated Curcumin Analog and Its Inclusion Complex with 2-Hydroxypropyl-β-Cyclodextrin against Pancreatic Cancer. International journal of molecular sciences 24 (7) (2023)
David Standing, Emma Feess, Satvik Kodiyalam, Michael Kuehn, Zachary Hamel, Jaimie Johnson, Sufi Mary Thomas, Shrikant Anant
The Role of STATs in Ovarian Cancer: Exploring Their Potential for Therapy. Cancers 15 (9) (2023)
David Standing, Emma Feess, Satvik Kodiyalam, Michael Kuehn, Zachary Hamel, Jaimie Johnson, Sufi Mary Thomas, Shrikant Anant
The Role of STATs in Ovarian Cancer: Exploring Their Potential for Therapy. Cancers 15 (9) (2023)
Sharon J Manley, Appolinaire A Olou, Jarrid L Jack, Mariana Tannús Ruckert, R McKinnon Walsh, Austin E Eades, Bailey A Bye, Joe Ambrose, Fanuel Messaggio, Shrikant Anant, Michael N VanSaun
Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells. Cell death & disease 13 (2) (2022)
Mohamed Alalem, Mrinalini Bhosale, Atul Ranjan, Satomi Yamamoto, Atsushi Kaida, Shigeto Nishikawa, Alejandro Parrales, Sana Farooki, Shrikant Anant, Subhash Padhye, Tomoo Iwakuma
Mutant p53 Depletion by Novel Inhibitors for HSP40/J-Domain Proteins Derived from the Natural Compound Plumbagin. Cancers 14 (17) (2022)
Sharon J Manley, Appolinaire A Olou, Jarrid L Jack, Mariana Tannús Ruckert, R McKinnon Walsh, Austin E Eades, Bailey A Bye, Joe Ambrose, Fanuel Messaggio, Shrikant Anant, Michael N VanSaun
Correction: Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells. Cell death & disease 13 (2) (2022)
Badal C Roy, Ishfaq Ahmed, Jason Stubbs, Limin Zhang, Thomas Attard, Seth Septer, Danny Welch, Shrikant Anant, Venkatesh Sampath, Shahid Umar
Correction: DCLK1 isoforms and aberrant Notch signaling in the regulation of human and murine colitis. Cell death discovery 7 (1) (2021)
Scott J Weir, Prasad Dandawate, David Standing, Sangita Bhattacharyya, Prabhu Ramamoorthy, Parthasarathy Rangarajan, Robyn Wood, Amanda E Brinker, Benjamin L Woolbright, Mehmet Tanol, Tammy Ham, William McCulloch, Michael Dalton, Gregory A Reed, Michael J Baltezor, Roy A Jensen, John A Taylor, Shrikant Anant
Fosciclopirox suppresses growth of high-grade urothelial cancer by targeting the γ-secretase complex. Cell death & disease 12 (6) (2021)
Badal C Roy, Ishfaq Ahmed, Jason Stubbs, Limin Zhang, Thomas Attard, Seth Septer, Danny Welch, Shrikant Anant, Venkatesh Sampath, Shahid Umar
DCLK1 isoforms and aberrant Notch signaling in the regulation of human and murine colitis. Cell death discovery 7 (1) (2021)
Prabhu Ramamoorthy, Prasad Dandawate, Roy A Jensen, Shrikant Anant
Celastrol and Triptolide Suppress Stemness in Triple Negative Breast Cancer: Notch as a Therapeutic Target for Stem Cells. Biomedicines 9 (5) (2021)
Benedikt Linder, Leonhard H F Köhler, Lisa Reisbeck, Dominic Menger, Dharmalingam Subramaniam, Christel Herold-Mende, Shrikant Anant, Rainer Schobert, Bernhard Biersack, Donat Kögel
A New Pentafluorothio-Substituted Curcuminoid with Superior Antitumor Activity. Biomolecules 11 (7) (2021)
Dharmalingam Subramaniam, Sivapriya Ponnurangam, Satish Ramalingam, Deep Kwatra, Prasad Dandawate, Scott J Weir, Shahid Umar, Roy A Jensen, Shrikant Anant
Honokiol Affects Stem Cell Viability by Suppressing Oncogenic YAP1 Function to Inhibit Colon Tumorigenesis. Cells 10 (7) (2021)
Taylor E Escher, Prasad Dandawate, Afreen Sayed, Christy R Hagan, Shrikant Anant, Joan Lewis-Wambi
Enhanced IFNα Signaling Promotes Ligand-Independent Activation of ERα to Promote Aromatase Inhibitor Resistance in Breast Cancer. Cancers 13 (20) (2021)
Ishfaq Ahmed, Kafayat Yusuf, Badal C Roy, Jason Stubbs, Shrikant Anant, Thomas M Attard, Venkatesh Sampath, Shahid Umar
Dietary Interventions Ameliorate Infectious Colitis by Restoring the Microbiome and Promoting Stem Cell Proliferation in Mice. International journal of molecular sciences 23 (1) (2021)
Prasad Dandawate, Dharmalingam Subramaniam, Peyton Panovich, David Standing, Balaji Krishnamachary, Gaurav Kaushik, Sufi Mary Thomas, Animesh Dhar, Scott J Weir, Roy A Jensen, Shrikant Anant
Cucurbitacin B and I inhibits colon cancer growth by targeting the Notch signaling pathway. Scientific reports 10 (1) (2020)
Connor Chestnut, Dharmalingam Subramaniam, Prasad Dandawate, Subhash Padhye, John Taylor, Scott Weir, Shrikant Anant
Targeting Major Signaling Pathways of Bladder Cancer with Phytochemicals: A Review. Nutrition and cancer (2020)
Dharmalingam Subramaniam, Pablo Angulo, Sivapriya Ponnurangam, Prasad Dandawate, Prabhu Ramamoorthy, Pugazhendhi Srinivasan, Tomoo Iwakuma, Scott J Weir, Katherine Chastain, Shrikant Anant
Suppressing STAT5 signaling affects osteosarcoma growth and stemness. Cell death & disease 11 (2) (2020)
Pratikkumar H Vekaria, Amar Kumar, Dharmalingam Subramaniam, Neil Dunavin, Anusha Vallurupalli, Frank Schoenen, Siddhartha Ganguly, Shrikant Anant, Joseph P McGuirk, Roy A Jensen, Rekha Rao
Functional cooperativity of p97 and histone deacetylase 6 in mediating DNA repair in mantle cell lymphoma cells. Leukemia 33 (7) (2019)

Shrikant Anant.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Shrikant Anant